A Comparison Study of Haemolysis Production in Three Contemporary Centrifugal Pumps
This study demonstrated that all three pumps produced low levels of haemolysis and are suitable for use in a clinical environment.
High-Risk Mitral Valve Surgery: What is the Role of Risk Calculators?
Current risk models provide important insight into the perioperative risk to the patient.
A Comparison of the Systems for the Identification of Postoperative Acute Kidney Injury in Pediatric Cardiac Patients
This study aimed to compare the three classifications for predicting AKI in pediatric patients undergoing cardiac operations.
Development of a New Selective Coronary Perfusion Cannula
We have examined the properties of a newly developed Kochi Medical School (KMS)-type cannula
Systemic Oxygen Delivery by Peritoneal Perfusion of Oxygen Microbubbles
Severe hypoxemia refractory to pulmonary mechanical ventilation remains life-threatening in critically ill patients.
Mitral Valve Repair
Mitral valve repair is the gold standard treatment for mitral regurgitation
Ischemia-Modified Albumin and Adenosine Plasma Concentrations are associated with Severe Systemic Inflammatory Response Syndrome after Cardiopulmonary Bypass
Adenosine plasma concentration and IMA concentration are associated with postoperative severe SIRS after CPB.
Cold Agglutinins in Patients undergoing Cardiac Surgery requiring Cardiopulmonary Bypass
Cold agglutinins (CA) are circulating autoantibodies present in most humans.
Update: IV Fluid Shortage
FDA is aware of the shortage situation for intravenous (IV) solutions, particularly 0.9% sodium chloride injection (i.e., saline)
Calcium gluconate 10 percent Injections by Rx Formulations: Recall – Microbial Contamination
FDA notified healthcare professionals to follow up with patients who received calcium gluconate 10% injections made by Rx Formulations, Mesa, Ariz., between Nov. 7 and Dec. 11, 2013.
Cardiopulmonary Bypass, Inflammation and How to Defy it: Focus on Pharmacological Interventions
One of the main untoward effects of CPB is systemic inflammation
ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 Multimodality Appropriate Use Criteria for the Detection and Risk Assessment of Stable Ischemic Heart Disease : A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Forc
The American College of Cardiology Foundation along with key specialty and subspecialty societies, conducted an appropriate use review of common clinical presentations for stable ischemic heart disease (SIHD) to consider use of stress testing and anatomic diagnostic procedures.